Gsa Capital Partners LLP Anixa Biosciences Inc Transaction History
Gsa Capital Partners LLP
- $1.11 Billion
- Q1 2025
A detailed history of Gsa Capital Partners LLP transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 75,804 shares of ANIX stock, worth $189,510. This represents 0.02% of its overall portfolio holdings.
Number of Shares
75,804Holding current value
$189,510% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
63Shares Held
5.48MCall Options Held
24.5KPut Options Held
23.4K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.48 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.56 Million0.29% of portfolio
-
D.A. Davidson & Co.614KShares$1.54 Million0.01% of portfolio
-
Ubs Group Ag524KShares$1.31 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.17 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $76.7M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...